Related Experiment Video
Updated: Jun 4, 2026
06:45
Integrated Photoacoustic, Ultrasound, and Angiographic Tomography (PAUSAT) for NonInvasive Whole-Brain Imaging of Ischemic Stroke
Published on: June 2, 2023
[Transcranial sonography in Parkinson's disease].
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova
|February 26, 2011
Summary
Transcranial sonography detects abnormal substantia nigra hyperechogenecity in most Parkinson's disease (PD) patients. This ultrasound biomarker aids in differentiating PD from similar neurological disorders, supporting early diagnosis.
Area of Science:
- Neurology
- Medical Imaging
- Neurosonology
Background:
- Substantia nigra hyperechogenecity is a key sonographic marker for Parkinson's disease (PD).
- Refining the specificity and sensitivity of ultrasound for PD diagnosis is crucial.
Purpose of the Study:
- To evaluate the diagnostic utility of transcranial sonography for Parkinson's disease.
- To assess the accuracy of substantia nigra hyperechogenecity in differentiating PD from other parkinsonian syndromes.
Main Methods:
- Utilized transcranial sonography to examine 168 patients with parkinsonism and 56 controls.
- Analyzed substantia nigra hyperechogenecity as a diagnostic biomarker.
Main Results:
- Substantia nigra hyperechogenecity was observed in 93% of PD patients versus 14% of controls.
- The biomarker effectively distinguished PD from essential tremor and atypical parkinsonian syndromes.
- Described sonographic features related to early, late, and genetic forms of parkinsonism.
Conclusions:
- Transcranial sonography is a highly informative tool for the differential and early diagnosis of Parkinson's disease.
- Substantia nigra hyperechogenecity shows significant diagnostic value in clinical practice.
Related Concept Videos
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
01:24Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
01:24Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
01:24Imaging Studies II: Ultrasonography
IntroductionUltrasonography, or renal ultrasound, is a noninvasive medical imaging technique that uses high-frequency sound waves to visualize the kidneys, ureters, bladder, and surrounding tissues.Indications for Urinary System UltrasonographyUrinary system ultrasonography is indicated in various clinical scenarios, such as:Kidney Stones (Urolithiasis): To detect and monitor the size and presence of kidney or urinary tract stones.Hydronephrosis: To assess the dilation of the renal pelvis and...